Cefoxitin and cephamycins: microbiological studies. 1979

E O Stapley, and J Birnbaum, and A K Miller, and H Wallick, and D Hendlin, and H B Woodruff
Merck Institute for Therapeutic Research, Rahway, New Jersey 07065.

The cephamycins are a family of beta-lactam antibiotics that are produced by actinomycetes and are structurally similar to the cephalosporins. They are characterized by the presence of a 7-alpha-methoxyl group, which confers unusually high resistance to beta-lactamases. Cefoxitin, the first semisynthetic cephamycin, is resistant to almost all beta-lactamases. Cefoxitin retains the 3-carbamoyl group of cephamycin C and thus has excellent metabolic stability. Cefoxitin is bactericidal and almost devoid of any inoculum effect. Active against many cephalothin-resistant gram-negative bacteria, cefoxitin demonstrates a very broad spectrum that includes indole-positive Proteus and many strains of Serratia. In contrast to that of the cephalosporins, cefoxitin's spectrum of activity against anaerobic pathogens includes Bacteroides fragilis. The therapeutic effectiveness of cefoxitin in experimental infections in mice confirms the excellent characteristics of this semisynthetic cephamycin and indicates that it should be a very valuable agent for treatment of bacterial infections.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002440 Cefoxitin A semisynthetic cephamycin antibiotic resistant to beta-lactamase. Cefoxitin Sodium,MK-306,Mefoxin,Mefoxitin,Méfoxin,MK 306,MK306,Sodium, Cefoxitin
D002513 Cephamycins Naturally occurring family of beta-lactam cephalosporin-type antibiotics having a 7-methoxy group and possessing marked resistance to the action of beta-lactamases from gram-positive and gram-negative organisms. Antibiotics, Cephamycin,Cephamycin,Cephamycin Antibiotics
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria
D006094 Gram-Positive Bacteria Bacteria which retain the crystal violet stain when treated by Gram's method. Gram Positive Bacteria
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001424 Bacterial Infections Infections by bacteria, general or unspecified. Bacterial Disease,Bacterial Infection,Infection, Bacterial,Infections, Bacterial,Bacterial Diseases
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

E O Stapley, and J Birnbaum, and A K Miller, and H Wallick, and D Hendlin, and H B Woodruff
March 1979, The Journal of antimicrobial chemotherapy,
E O Stapley, and J Birnbaum, and A K Miller, and H Wallick, and D Hendlin, and H B Woodruff
January 1978, The Journal of antibiotics,
E O Stapley, and J Birnbaum, and A K Miller, and H Wallick, and D Hendlin, and H B Woodruff
January 2007, Journal of AOAC International,
E O Stapley, and J Birnbaum, and A K Miller, and H Wallick, and D Hendlin, and H B Woodruff
January 1999, Antonie van Leeuwenhoek,
E O Stapley, and J Birnbaum, and A K Miller, and H Wallick, and D Hendlin, and H B Woodruff
January 1978, Scandinavian journal of infectious diseases. Supplementum,
E O Stapley, and J Birnbaum, and A K Miller, and H Wallick, and D Hendlin, and H B Woodruff
May 1978, The Medical journal of Australia,
E O Stapley, and J Birnbaum, and A K Miller, and H Wallick, and D Hendlin, and H B Woodruff
April 1979, The Journal of antibiotics,
E O Stapley, and J Birnbaum, and A K Miller, and H Wallick, and D Hendlin, and H B Woodruff
January 1978, Scandinavian journal of infectious diseases. Supplementum,
E O Stapley, and J Birnbaum, and A K Miller, and H Wallick, and D Hendlin, and H B Woodruff
February 1956, Forschungen und Fortschritte; Nachrichtenblatt der deutschen Wissenschaft und Technik,
E O Stapley, and J Birnbaum, and A K Miller, and H Wallick, and D Hendlin, and H B Woodruff
January 1979, Reviews of infectious diseases,
Copied contents to your clipboard!